Literature DB >> 15838487

Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.

David J Brown1, Eva M Rzucidlo, Bethany L Merenick, Robert J Wagner, Kathleen A Martin, Richard J Powell.   

Abstract

OBJECTIVE: Interactions between endothelial cells (ECs) and smooth muscle cells (SMCs) are fundamental in diverse cardiovascular processes such as arteriogenesis, atherosclerosis, and restenosis. We aimed to determine the intracellular signaling mechanisms by which ECs promote a differentiated SMC phenotype.
METHODS: Bovine thoracic aorta ECs and SMCs were isolated and cultured. For co-culture studies, ECs were grown to confluence on one side of a semi-permeable Cyclopore membrane. SMCs were then plated on the opposite side of the membrane and cultured for 24 to 48 hours. For adenovirus experiments, SMCs were infected prior to plating opposite ECs. For conditioned media studies, SMCs cultured alone on plastic were treated with media harvested from EC/SMC in co-culture. SMC phenotype was assayed by microscopy and measurement of two-dimensional area, or by western blotting for contractile protein markers of differentiation. Akt activation was measured by western blotting for phospho-Serine 473.
RESULTS: Although SMCs cultured alone exhibit a dedifferentiated synthetic phenotype, we report that bilayer co-culture with ECs induced a differentiated SMC phenotype as measured by morphology and cell area and expression of protein markers of differentiation, including contractile proteins and the cyclin-dependent kinase inhibitor p27 kip . The EC/SMC bilayer co-culture resulted in activation of the SMC protein kinase Akt, with no effect on total Akt expression. Similarly, conditioned media from co-cultured EC/SMC promoted rapid Akt phosphorylation and subsequent expression of differentiation protein markers in SMCs cultured alone. Adenoviral overexpression of constitutively active Akt in SMCs cultured alone mimicked the ability of ECs to induce SMC differentiation. Notably, inhibition of phosphoinositide 3 (PI 3)-kinase activity with wortmannin or adenoviral overexpression of a dominant-negative Akt prevented the EC-mediated effect on SMC morphology and differentiation protein marker expression.
CONCLUSIONS: ECs direct SMCs towards a differentiated phenotype through activation of the SMC PI 3-kinase/Akt pathway. CLINICAL RELEVANCE: Interactions between endothelial cells (ECs) and smooth muscle cells (SMCs) are fundamental in diverse cardiovascular processes such as arteriogenesis, collateral blood vessel development, atherosclerosis, and restenosis. Alterations in SMC phenotype occur in each of these processes. Endothelial denudation has been suggested to contribute to the SMC proliferative response to vessel injury by angioplasty or other catheterization procedures. We have employed a co-culture approach to dissect the molecular signals that are dependent on the spatial relationship between ECs and SMCs, and have identified the importance of the PI3K/Akt pathway in EC-induced SMC differentiation. This pathway may suggest targets for therapeutic interventions for intimal hyperplasia and restenosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838487     DOI: 10.1016/j.jvs.2004.12.024

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  20 in total

1.  Role of cyclic strain frequency in regulating the alignment of vascular smooth muscle cells in vitro.

Authors:  Bo Liu; Ming-Juan Qu; Kai-Rong Qin; He Li; Zhen-Kun Li; Bao-Rong Shen; Zong-Lai Jiang
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

Review 2.  The critical role of Akt in cardiovascular function.

Authors:  Prasanna Abeyrathna; Yunchao Su
Journal:  Vascul Pharmacol       Date:  2015-05-27       Impact factor: 5.773

3.  Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Authors:  Somali Chaterji; Kinam Park; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

4.  Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence.

Authors:  Laurie D Deleve; Xiangdong Wang; Yumei Guo
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

5.  Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.

Authors:  Yu-Miao Wei; Xiang Li; Ming Xu; Justine M Abais; Yang Chen; Christopher R Riebling; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  Cell Physiol Biochem       Date:  2013-06-18

Review 6.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

7.  Late-outgrowth endothelial progenitors from patients with coronary artery disease: endothelialization of confluent stromal cell layers.

Authors:  Cristina E Fernandez; Izundu C Obi-onuoha; Charles S Wallace; Lisa L Satterwhite; George A Truskey; William M Reichert
Journal:  Acta Biomater       Date:  2013-10-16       Impact factor: 8.947

8.  Regulation of vascular smooth muscle cell phenotype in three-dimensional coculture system by Jagged1-selective Notch3 signaling.

Authors:  Aparna Bhattacharyya; Shigang Lin; Martin Sandig; Kibret Mequanint
Journal:  Tissue Eng Part A       Date:  2014-02-10       Impact factor: 3.845

9.  Spry1 and Spry4 differentially regulate human aortic smooth muscle cell phenotype via Akt/FoxO/myocardin signaling.

Authors:  Xuehui Yang; Yan Gong; Yuefeng Tang; Hongfang Li; Qing He; Lindsey Gower; Lucy Liaw; Robert E Friesel
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Functional vascular smooth muscle-like cells derived from adult mouse uterine mesothelial cells.

Authors:  Christian Claude Lachaud; Daniela Pezzolla; Alejandro Domínguez-Rodríguez; Tarik Smani; Bernat Soria; Abdelkrim Hmadcha
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.